These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 21327253
1. A simple and fast microfluidic approach of same-single-cell analysis (SASCA) for the study of multidrug resistance modulation in cancer cells. Li X, Chen Y, Li PC. Lab Chip; 2011 Apr 07; 11(7):1378-84. PubMed ID: 21327253 [Abstract] [Full Text] [Related]
2. Same-single-cell analysis for the study of drug efflux modulation of multidrug resistant cells using a microfluidic chip. Li X, Ling V, Li PC. Anal Chem; 2008 Jun 01; 80(11):4095-102. PubMed ID: 18447319 [Abstract] [Full Text] [Related]
3. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells. Koshkin V, Krylov SN. Anal Chem; 2011 Aug 15; 83(16):6132-4. PubMed ID: 21770449 [Abstract] [Full Text] [Related]
4. Dielectrophoretic Microfluidic Chip Enables Single-Cell Measurements for Multidrug Resistance in Heterogeneous Acute Myeloid Leukemia Patient Samples. Khamenehfar A, Gandhi MK, Chen Y, Hogge DE, Li PC. Anal Chem; 2016 Jun 07; 88(11):5680-8. PubMed ID: 27149245 [Abstract] [Full Text] [Related]
5. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH. Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169 [Abstract] [Full Text] [Related]
6. Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation. Khamenehfar A, Wan CP, Li PC, Letchford K, Burt HM. Anal Bioanal Chem; 2014 Nov 21; 406(28):7071-83. PubMed ID: 25315452 [Abstract] [Full Text] [Related]
7. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW. J Pharm Pharmacol; 2004 Aug 21; 56(8):1061-6. PubMed ID: 15285852 [Abstract] [Full Text] [Related]
8. A microfluidic array with cellular valving for single cell co-culture. Frimat JP, Becker M, Chiang YY, Marggraf U, Janasek D, Hengstler JG, Franzke J, West J. Lab Chip; 2011 Jan 21; 11(2):231-7. PubMed ID: 20978708 [Abstract] [Full Text] [Related]
9. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells. Hasegawa T, Bai J, Dai J, Bai L, Sakai J, Nishizawa S, Bai Y, Kikuchi M, Abe M, Yamori T, Tomida A, Tsuruo T, Hirose K, Ando M. Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3722-8. PubMed ID: 17490878 [Abstract] [Full Text] [Related]
10. Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review. Liu FS. Taiwan J Obstet Gynecol; 2009 Sep 01; 48(3):239-44. PubMed ID: 19797012 [Abstract] [Full Text] [Related]
11. Reversal of cancer multidrug resistance by green tea polyphenols. Mei Y, Qian F, Wei D, Liu J. J Pharm Pharmacol; 2004 Oct 01; 56(10):1307-14. PubMed ID: 15482646 [Abstract] [Full Text] [Related]
12. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line. Lelong-Rebel I, Brisson C, Fabre M, Bergerat JP, Rebel G. Anticancer Res; 2008 Oct 01; 28(1A):55-68. PubMed ID: 18383825 [Abstract] [Full Text] [Related]
13. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. Fong WF, Wang C, Zhu GY, Leung CH, Yang MS, Cheung HY. Phytomedicine; 2007 Feb 01; 14(2-3):160-5. PubMed ID: 16713217 [Abstract] [Full Text] [Related]
14. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A. Anticancer Res; 2004 Feb 01; 24(2B):865-71. PubMed ID: 15161039 [Abstract] [Full Text] [Related]
15. Complete reversal by thaliblastine of 490-fold adriamycin resistance in multidrug-resistant (MDR) human breast cancer cells. Evidence that multiple biochemical changes in MDR cells need not correspond to multiple functional determinants for drug resistance. Chen G, Waxman DJ. J Pharmacol Exp Ther; 1995 Sep 01; 274(3):1271-7. PubMed ID: 7562498 [Abstract] [Full Text] [Related]
16. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B. Pharmazie; 2008 Jul 01; 63(7):528-33. PubMed ID: 18717489 [Abstract] [Full Text] [Related]
17. Rapid diagnosis of multidrug resistance in cancer by electrochemical sensor based on carbon nanotubes-drug supramolecular nanocomposites. Zhang H, Jiang H, Sun F, Wang H, Zhao J, Chen B, Wang X. Biosens Bioelectron; 2011 Mar 15; 26(7):3361-6. PubMed ID: 21300536 [Abstract] [Full Text] [Related]
18. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Peer D, Dekel Y, Melikhov D, Margalit R. Cancer Res; 2004 Oct 15; 64(20):7562-9. PubMed ID: 15492283 [Abstract] [Full Text] [Related]
19. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, Manfait M, Sockalingum GD. Biopolymers; 2006 Aug 05; 82(5):462-70. PubMed ID: 16493658 [Abstract] [Full Text] [Related]
20. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G, Orlandi M, Papi A, Ammar K, Guerra F, Ferreri AM, Rocchi P. In Vivo; 2006 Aug 05; 20(6A):729-33. PubMed ID: 17203756 [Abstract] [Full Text] [Related] Page: [Next] [New Search]